Your browser doesn't support javascript.
loading
Italian translation and validation of fatigue symptoms and impacts questionnaire in relapsing multiple sclerosis (FSIQ-RMS).
Ruotolo, Ilaria; Sellitto, Giovanni; Ianniello, Antonio; Petsas, Nikolaos; Castelli, Letizia; Galeoto, Giovanni; Berardi, Anna; Barletta, Valeria; Conte, Antonella; Pozzilli, Carlo.
Afiliação
  • Ruotolo I; MS Center, S. Andrea Hospital, Sapienza University, Rome, Italy. ilariaruotolo9696@gmail.com.
  • Sellitto G; MS Center, S. Andrea Hospital, Sapienza University, Rome, Italy.
  • Ianniello A; Department of Human Neurosciences, Sapienza University, Rome, Italy.
  • Petsas N; IRCCS Neuromed, Pozzilli, Italy.
  • Castelli L; Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
  • Galeoto G; Department of Human Neurosciences, Sapienza University, Rome, Italy.
  • Berardi A; Department of Human Neurosciences, Sapienza University, Rome, Italy.
  • Barletta V; Department of Human Neurosciences, Sapienza University, Rome, Italy.
  • Conte A; Department of Human Neurosciences, Sapienza University, Rome, Italy.
  • Pozzilli C; IRCCS Neuromed, Pozzilli, Italy.
Neurol Sci ; 43(8): 4925-4932, 2022 Aug.
Article em En | MEDLINE | ID: mdl-35451663
ABSTRACT

BACKGROUND:

Fatigue is a disabling symptom of multiple sclerosis (MS) and impacts on daily life. The Fatigue Symptoms and Impacts Questionnaire-Relapsing Multiple Sclerosis (FSIQ-RMS) is a new 20-item tool that investigates the aspects of fatigue in MS. It concerns motor, cognitive, social, and emotional aspects of fatigue. We aim at validating the Italian version of FSIQ-RMS in an Italian population of MS patients and demonstrate its reliability and construct validity.

METHODS:

We included patients with diagnosis of MS, age between 18 and 70 years with ability to participate in a 90-min interview. Each patient completed the Italian version of FSIQ-RMS and Fatigue Severity Scale (FSS) at the same time. Construct validity was explored by the exploratory factor analysis; reliability was assessed with Cronbach's alpha; and test-retest stability was examined through intraclass correlation coefficient (ICC). Concurrent validity was calculated using Pearson's correlation.

RESULTS:

We enrolled 171 patients (126 female and 45 male), 83% with relapsing MS (RMS), and 17% with secondary progressive MS (SPMS). Italian FSIQ-RMS showed a Cronbach's alpha of 0.92; ICC was 0.96. Pearson's correlation coefficient between FSIQ-RMS and FSS total score was statistically significant (p < 0.01); FSIQ-RMS inversely correlated also with BMI and positively with EDSS.

CONCLUSION:

The Italian version of FSIQ-RMS has excellent psychometric properties and can be used in research and clinical setting to evaluate physical, cognitive, and social fatigue in both RMS and SPMS.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esclerose Múltipla Tipo de estudo: Diagnostic_studies / Etiology_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Neurol Sci Assunto da revista: NEUROLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esclerose Múltipla Tipo de estudo: Diagnostic_studies / Etiology_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Neurol Sci Assunto da revista: NEUROLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Itália